Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Comparative Effects of Methylphenidate, Modafinil, and MDMA on Response Inhibition Neural Networks in Healthy Subjects
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 3896693
Author(s) Schmidt, André; Müller, Felix; Dolder, Patrick C.; Schmid, Yasmin; Zanchi, Davide; Liechti, Matthias E.; Borgwardt, Stefan
Author(s) at UniBasel Liechti, Matthias Emanuel
Schmidt, André
Year 2017
Title Comparative Effects of Methylphenidate, Modafinil, and MDMA on Response Inhibition Neural Networks in Healthy Subjects
Journal International Journal of Neuropsychopharmacology
Volume 20
Number 9
Pages / Article-Number 712-720
Mesh terms Benzhydryl Compounds, pharmacology; Brain, drug effects; Brain Mapping; Central Nervous System Stimulants, pharmacology; Cognition, drug effects; Cross-Over Studies; Double-Blind Method; Emotions, drug effects; Female; Hallucinogens, pharmacology; Healthy Volunteers; Humans; Image Processing, Computer-Assisted; Inhibition (Psychology); Magnetic Resonance Imaging; Male; Methylphenidate, pharmacology; N-Methyl-3,4-methylenedioxyamphetamine, pharmacology; Neural Pathways, drug effects; Oxygen, blood; Psychometrics
Abstract Psychostimulants such as methylphenidate and modafinil are increasingly used by healthy people for cognitive enhancement purposes, whereas the acute effect of 3,4-methylenedioxymethamphetamine (ecstasy) on cognitive functioning in healthy subjects remains unclear. This study directly compared the acute effects of methylphenidate, modafinil, and 3,4-methylenedioxymethamphetamine on the neural mechanisms underlying response inhibition in healthy subjects.; Using a double-blind, within-subject, placebo-controlled, cross-over design, methylphenidate, modafinil, and 3,4-methylenedioxymethamphetamine were administrated to 21 healthy subjects while performing a go/no-go event-related functional magnetic resonance imaging task to assess brain activation during motor response inhibition.; Relative to placebo, methylphenidate and modafinil but not 3,4-methylenedioxymethamphetamine improved inhibitory performance. Methylphenidate significantly increased activation in the right middle frontal gyrus, middle/superior temporal gyrus, inferior parietal lobule, presupplementary motor area, and anterior cingulate cortex compared with placebo. Methylphenidate also induced significantly higher activation in the anterior cingulate cortex and presupplementary motor area and relative to modafinil. Relative to placebo, modafinil significantly increased activation in the right middle frontal gyrus and superior/inferior parietal lobule, while 3,4-methylenedioxymethamphetamine significantly increased activation in the right middle/inferior frontal gyrus and superior parietal lobule.; Direct comparison of methylphenidate, modafinil, and 3,4-methylenedioxymethamphetamine revealed broad recruitment of fronto-parietal regions but specific effects of methylphenidate on middle/superior temporal gyrus, anterior cingulate cortex, and presupplementary motor area activation, suggesting dissociable modulations of response inhibition networks and potentially the superiority of methylphenidate in the enhancement of cognitive performance in healthy subjects.
Publisher Oxford University Press
ISSN/ISBN 1461-1457 ; 1469-5111
URL https://academic.oup.com/ijnp/article/20/9/712/3835335
edoc-URL http://edoc.unibas.ch/56150/
Full Text on edoc Available
Digital Object Identifier DOI 10.1093/ijnp/pyx037
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/28525569
ISI-Number WOS:000412072200004
Document type (ISI) Article
 
   

MCSS v5.8 PRO. 0.354 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
05/05/2024